论文部分内容阅读
目的：观察β—七叶皂甙钠治疗脑溢血疗效；方法：临床上选择诊断明确脑溢血病人３２例，男性２０例，女性１２例，年龄分布４０～９０岁（平均６６岁），脑ＣＴ出血量小于３０ｍＬ者静脉滴注β—七叶皂甙钠２５ｍＬ每天一次，大于３０ｍＬ者２５ｍｇ每天二次。１４ｄ为一疗程；结果：痊愈６３．５％，有效３６．５％。症状体征上看痊愈８９．２６％，有效１０．７４％。本组病人均无副反应；结论：β—七叶皂甙钠治疗脑溢血是一种有效、安全、副作用少的药物，价格低廉，为部分脑溢血者开辟了一条新的途径
Objective: To observe the efficacy of β-aescinate in the treatment of cerebral hemorrhage; Methods: Clinically choose to diagnose 32 patients with cerebral hemorrhage, including 20 males and 12 females, with an age distribution of 40-90 years (average 66 years old), brain CT hemorrhage is less than 30mL intravenous β-aescin sodium 25mL once a day, more than 30mL 25mg twice daily. 14d was a course of treatment; results: Healed 63.5%, effective 36.5%. The recovery of symptoms and signs was 89.26%, effective 10.74%. There was no side effect in this group of patients; Conclusion: β-aescin sodium is a kind of effective, safe and less side-effect drug for treatment of cerebral hemorrhage, which has opened up a new way for some patients with cerebral hemorrhage.